Medicare Enrolled
Dr. David Ross, MD
Medical Oncology · Rockledge, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ross?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ross
Dr. David Ross is a medical oncology specialist in Rockledge, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ross performed 114,950 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ross received a total of $25,919 from 88 pharmaceutical and/or device companies across 1142 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in FL
$25,919 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 90807 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗114,950
Medicare services
Top 22% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
26,250 | $1 | $5 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
19,960 | $2 | $21 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
14,700 | $0 | $7 |
| Pembrolizumab injection (Keytruda) | 10,400 | $43 | $147 |
| Denosumab injection (Prolia/Xgeva) | 10,140 | $18 | $70 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
9,900 | $0 | $36 |
| Paclitaxel chemotherapy injection | 3,728 | $0 | $1 |
| Iron infusion (Monoferric) | 3,200 | $17 | $74 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,970 | $33 | $250 |
| Injection, degarelix, 1 mg | 1,800 | $3 | $17 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,614 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $122 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,000 | $8 | $35 |
| Anti-nausea injection (ondansetron/Zofran) | 880 | $0 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
715 | $67 | $180 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
550 | $8 | $19 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
530 | $6 | $30 |
| Injection, leucovorin calcium, per 50 mg | 516 | $3 | $27 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
474 | $2 | $14 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
473 | $99 | $686 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
434 | $22 | $152 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
426 | $11 | $93 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
327 | $2 | $94 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $96 | $224 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
220 | $54 | $270 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
211 | $1 | $19 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
210 | $47 | $304 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
190 | $2 | $19 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
183 | $2 | $300 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
145 | $73 | $243 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
141 | $16 | $97 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
133 | $22 | $156 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $127 | $3,938 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
114 | $26 | $141 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
104 | $18 | $111 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $128 | $420 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
88 | $10 | $73 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
82 | $50 | $334 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
77 | $25 | $249 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
77 | $1 | $7 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
46 | $133 | $986 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
42 | $12 | $105 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
42 | $1 | $19 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
37 | $50 | $168 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
32 | $15 | $91 |
| New patient office visit, complex (60-74 min) | 30 | $172 | $432 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $133 | $360 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
17 | $66 | $189 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
29.7% high complexity
67.6% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,919
Total received (2018-2024)
Avg $3,703/year across 7 years
Top 20% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,142
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,496
2023
$3,479
2022
$4,566
2021
$3,903
2020
$3,559
2019
$3,170
2018
$2,746
Payments by company (2024)
Janssen Biotech, Inc.
$481
AstraZeneca Pharmaceuticals LP
$474
PFIZER INC.
$422
Merck Sharp & Dohme LLC
$240
Novartis Pharmaceuticals Corporation
$238
Lilly USA, LLC
$168
Genmab U.S., Inc.
$158
Gilead Sciences, Inc.
$144
ABBVIE INC.
$140
Celgene Corporation
$133
Daiichi Sankyo Inc.
$130
Incyte Corporation
$118
Takeda Pharmaceuticals U.S.A., Inc.
$105
Eisai Inc.
$105
Genentech USA, Inc.
$94
Astellas Pharma US Inc
$85
BeiGene USA, Inc.
$81
GENZYME CORPORATION
$80
Coherus Biosciences Inc.
$77
SERVIER PHARMACEUTICALS LLC
$74
Karyopharm Therapeutics Inc.
$70
Alexion Pharmaceuticals, Inc.
$64
E.R. Squibb & Sons, L.L.C.
$64
SOBI, INC
$62
Regeneron Healthcare Solutions, Inc.
$60
Pharmacosmos Therapeutics Inc.
$58
EMD Serono, Inc.
$53
JAZZ PHARMACEUTICALS INC.
$47
GlaxoSmithKline, LLC.
$46
Agios Pharmaceuticals, Inc.
$42
Exelixis Inc.
$40
Rigel Pharmaceuticals, Inc.
$39
PUMA BIOTECHNOLOGY, INC.
$34
PharmaEssentia USA Corporation
$33
ADC Therapeutics America, Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
Ipsen Biopharmaceuticals, Inc
$25
Biocon Biologics Inc
$25
ARRAY BIOPHARMA INC
$23
Menarini Silicon Biosystems, Inc.
$22
Fennec Pharmaceuticals, Inc.
$21
TAIHO ONCOLOGY, INC.
$21
Bayer Healthcare Pharmaceuticals Inc.
$18
Iovance Biotherapeutics, Inc.
$16
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 30.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,368
Janssen Biotech, Inc.
$1,982
PFIZER INC.
$1,750
Novartis Pharmaceuticals Corporation
$1,713
E.R. Squibb & Sons, L.L.C.
$1,591
Seagen Inc.
$1,091
Genentech USA, Inc.
$1,006
Amgen Inc.
$913
Incyte Corporation
$821
Celgene Corporation
$758
GENZYME CORPORATION
$729
Merck Sharp & Dohme LLC
$666
Lilly USA, LLC
$648
Takeda Pharmaceuticals U.S.A., Inc.
$537
Daiichi Sankyo Inc.
$510
Astellas Pharma US Inc
$493
Ipsen Biopharmaceuticals, Inc
$493
Merck Sharp & Dohme Corporation
$493
Regeneron Healthcare Solutions, Inc.
$471
Bayer HealthCare Pharmaceuticals Inc.
$405
GlaxoSmithKline, LLC.
$357
Eisai Inc.
$332
Janssen Scientific Affairs, LLC
$287
Pharmacyclics LLC, An AbbVie Company
$275
Gilead Sciences, Inc.
$265
JAZZ PHARMACEUTICALS INC.
$263
Boehringer Ingelheim Pharmaceuticals, Inc.
$238
Puma Biotechnology, Inc.
$236
AbbVie, Inc.
$200
EMD Serono, Inc.
$182
Karyopharm Therapeutics Inc.
$181
Genmab U.S., Inc.
$158
ABBVIE INC.
$158
Kite Pharma, Inc.
$152
Rigel Pharmaceuticals, Inc.
$146
SERVIER PHARMACEUTICALS LLC
$143
AbbVie Inc.
$142
Alexion Pharmaceuticals, Inc.
$127
Celltrion USA Inc.
$119
ARRAY BIOPHARMA INC
$115
Immunomedics, Inc.
$114
BeiGene USA, Inc.
$109
Pharmacyclics LLC, an AbbVie Company
$106
SOBI, INC
$106
Taiho Oncology, Inc.
$103
Exelixis Inc.
$101
Mirati Therapeutics, Inc.
$98
Pharmacosmos Therapeutics Inc.
$97
EISAI INC.
$88
Deciphera Pharmaceuticals Inc.
$86
Clovis Oncology, Inc.
$82
Agios Pharmaceuticals, Inc.
$77
Coherus Biosciences Inc.
$77
ADC Therapeutics America, Inc.
$75
Myovant Sciences Inc.
$71
PUMA BIOTECHNOLOGY, INC.
$67
Epizyme, Inc.,
$67
G1 Therapeutics, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$64
Jazz Pharmaceuticals Inc.
$55
TESARO, Inc.
$48
TG THERAPEUTICS, INC.
$47
Seattle Genetics, Inc.
$43
TOLMAR Pharmaceuticals, Inc.
$39
Acceleron Pharma, Inc.
$36
Dova Pharmaceuticals
$35
PharmaEssentia USA Corporation
$33
Global Blood Therapeutics, Inc.
$29
TerSera Therapeutics LLC
$29
Biocon Biologics Inc
$25
Sumitomo Pharma America, Inc.
$24
CTI BioPharma Corp.
$24
Sun Pharmaceutical Industries Inc.
$22
Menarini Silicon Biosystems, Inc.
$22
Fennec Pharmaceuticals, Inc.
$21
Blueprint Medicines Corporation
$21
TAIHO ONCOLOGY, INC.
$21
Foundation Medicine, Inc.
$20
Advanced Accelerator Applications
$20
MorphoSys, US Inc.
$19
AMAG Pharmaceuticals, Inc.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$17
Iovance Biotherapeutics, Inc.
$16
Stemline Therapeutics Inc.
$16
MACROGENICS, INC.
$14
Sobi, Inc
$14
Azurity Pharmaceuticals, Inc.
$14
Verity Pharmaceuticals Inc.
$13
Top 3 companies account for 23.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FERAHEME · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · Mavenclad · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tecentriq Hybreza · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Veozah · Vitrakvi · Vonjo · Voranigo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
6
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH ROCKLEDGE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ross is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ross experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Ross performed 26,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ross receive payments from pharmaceutical companies?
Yes. Dr. Ross received a total of $25,919 from 88 companies across 1,142 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ross's costs compare to other medical oncologists in Rockledge?
Dr. Ross's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Rockledge
Browse medical oncologists in Rockledge ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology